Freely Filtered 054: EMPA Kidney!
Freely Filtered, a NephJC Podcast
00:00
Are You Done?
All three renal outcome trials now of SGLD two inhibitors have been stopped based on pre specified efficacy criteria just astounding really I think and also from an interpretation perspective one one thing is that does reduce the power to detect you know treatment effects in particular subgroups. You can see recruitment just drop off a cliff in the start of 2020 and then come back up again with COVID. This was only done in about eight or nine countries so this these were highly recruit these all centers recruited really well it was a streamlined design.
Transcript
Play full episode
